CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression
Malinee Thanee(Khon Kaen University), Watcharin Loilome(Khon Kaen University)
Cited by 19
Related Papers
CD44 variant‐dependent redox status regulation in liver fluke‐associated cholangiocarcinoma: A target for cholangiocarcinoma treatment
|Cancer Science|2016|69
PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma
|International Journal of Cancer|2010|60
Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells
|Oncology Reports|2016|40